Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 7531 AL 7545

Progressive nonfluent aphasia: a rare clinical subtype of FTLD-TDP in Japan

Aoki N, Tsuchiya K, Kobayashi Z, Arai T, Togo T, Miyazaki H, Kondo H, Ishizu H, Uchikado H, Katsuse O, Hirayasu Y, Akiyama H.

Neuropathology. 2012 Jun;32(3):272-9. doi: 10.1111/j.1440-1789.2011.01253.x. Epub 2011 Oct 6.

Movement disorder as prodrome of schizophrenia

Lin Z, Chuah A, Mohan T, Dhillon R, Bastiampillai T.

Aust N Z J Psychiatry. 2011 Oct;45(10):904. doi: 10.3109/00048674.2011.591287.

Deep brain stimulation response in pathologically confirmed cases of multiple system atrophy

Ullman M, Vedam-Mai V, Resnick AS, Yachnis AT, McFarland NR, Merritt S, Zeilman P, Foote KD, Okun MS.

Parkinsonism Relat Disord. 2012 Jan;18(1):86-8. doi: 10.1016/j.parkreldis.2011.09.008. Epub 2011 Oct 7.

Mapping the central neurocircuitry that integrates the cardiovascular response to exercise in humans

Basnayake SD, Green AL, Paterson DJ.

Exp Physiol. 2012 Jan;97(1):29-38. doi: 10.1113/expphysiol.2011.060848. Epub 2011 Oct 7.

Electrode dysfunctions in patients with deep brain stimulation: a clinical retrospective study

Allert N, Markou M, Miskiewicz AA, Nolden L, Karbe H.

Acta Neurochir (Wien). 2011 Dec;153(12):2343-9. doi: 10.1007/s00701-011-1187-y. Epub 2011 Oct 12.

Nitric oxide modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders

Pierucci M, Galati S, Valentino M, Di Matteo V, Benigno A, Pitruzzella A, Muscat R, Di Giovanni G.

CNS Neurol Disord Drug Targets. 2011 Nov;10(7):777-91. doi: 10.2174/187152711798072329.

Synchrotron-generated microbeam radiosurgery: a novel experimental approach to modulate brain function

Romanelli P, Bravin A.

Neurol Res. 2011 Oct;33(8):825-31. doi: 10.1179/016164111X13123658647445.

Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders

Jankovic J, Clarence-Smith K.

Expert Rev Neurother. 2011 Nov;11(11):1509-23. doi: 10.1586/ern.11.149.

[A case of amyotrophic lateral sclerosis with bilateral vocal cord paralysis necessitating tracheotomy]

Arai M, Endo S, Oshima G, Yagi Y.

Rinsho Shinkeigaku. 2011 Oct;51(10):765-9. doi: 10.5692/clinicalneurol.51.765.

Prevalence and diagnostic challenge of dystonia in Thailand: a service-based study in a tertiary university referral centre

Bhidayasiri R, Kaewwilai L, Wannachai N, Brenden N, Truong DD, Devahastin R.

Parkinsonism Relat Disord. 2011 Nov;17 Suppl 1:S15-9. doi: 10.1016/j.parkreldis.2011.06.014.

Improvement of tardive dyskinesia and dystonia associated with aripiprazole following a switch to quetiapine: case report and review of the literature

Ono S, Suzuki Y, Shindo M, Endo T, Fukui N, Sugai T, Someya T.

J Clin Pharm Ther. 2012 Jun;37(3):370-2. doi: 10.1111/j.1365-2710.2011.01290.x. Epub 2011 Oct 24.

Neuroacanthocytosis syndromes

Jung HH, Danek A, Walker RH.

Orphanet J Rare Dis. 2011 Oct 25;6:68. doi: 10.1186/1750-1172-6-68.

Acute movement disorder with bilateral basal ganglia lesions in diabetic uremia

Wali GM, Khanpet MS, Mali RV.

Ann Indian Acad Neurol. 2011 Jul;14(3):211-3. doi: 10.4103/0972-2327.85899.

L-2-hydroxyglutaric aciduria diagnosed in a young adult with progressive cerebellar ataxia and facial dyskinesia

Marcel C, Mallaret M, Lagha-Boukbiza O, Kremer S, Echaniz-Laguna A, Tranchant C.

Rev Neurol (Paris). 2012 Feb;168(2):187-91. doi: 10.1016/j.neurol.2011.06.002. Epub 2011 Oct 24.

Primary dystonia and dystonia-plus syndromes: clinical characteristics, diagnosis, and pathogenesis

Phukan J, Albanese A, Gasser T, Warner T.

Lancet Neurol. 2011 Dec;10(12):1074-85. doi: 10.1016/S1474-4422(11)70232-0. Epub 2011 Oct 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias